Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

tiotropium 0.018 MG Inhalant Powder

Known as: TIOTROPIUM 18MCG INHL CAP 30, TIOTROPIUM 18MCG CAP,INHL,30, TIOTROPIUM 18MCG INHL CAP 90 
 
National Institutes of Health

Related topics

Related topics

6 relations
AsthmaBronchodilation [PE]Inhalant Powdertiotropium

Broader (1)

BRONCHODILATORS,ANTICHOLINERGIC

Narrower (1)

tiotropium 0.018 MG Inhalant Powder [Spiriva]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Exacerbation Rates and Healthcare Resource Utilization (HRU) in Asthma Patients Initiating Tiotropium Respimat (Tio-RMT)
 
Is this relevant?
Review
2017
Review
2017
A review of the efficacy and safety of once-daily tiotropium Respimat 2.5 micrograms in adults and adolescents with asthma.
BACKGROUND Despite current guidelines, many patients with asthma remain symptomatic, particularly those intolerant of… Expand
Is this relevant?
2017
2017
Effet de l’association tiotropium et olodaterol prise une fois par jour pendant 8 et 12 semaines, seule et combinée à l’entraînement physique, sur l’endurance à l’exercice lors de la marche chez les…
Introduction Le deconditionnement physique est frequent chez les patients atteints de BPCO, ce qui limite la tolerance a l… Expand
Is this relevant?
2016
2016
Pharmacokinetics of tiotropium in asthma patients from three paediatric clinical trials
Background: Studies in adult patients (pts) with asthma have shown that once-daily (QD) tiotropium Respimat ® (tioR) exhibits an… Expand
Is this relevant?
2008
2008
Pharmacokinetics and tolerability (Study 1) with particular reference to ocular safety (Study 2) of tiotropium Respimat® Soft Mist™ Inhaler: findings from two dose-ranging studies in healthy men
Data are presented from two randomized, double-blind, placebo-controlled studies in which the tolerability of tiotropium Respimat… Expand
  • table 1
  • figure 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE